Skip to content
Taxonomy
Studying Neurodegeneration in CMT1X Mouse Model
In people with CMT1X cell-to-cell communication within the peripheral nervous Read More
Establishing gene therapy strategies for CMT2E
CMT2E is caused by dominant or recessive mutations in the Read More
CMTA to attend the annual BIO partnering conference in Boston
The CMTA is a global leader in the acceleration of Read More
CMTA Adds Science Writer Kenneth Raymond to Team
On April 17, 2023, the Charcot-Marie-Tooth Association welcomed Kenneth Raymond Read More
CMTA Partnering is Open for Business
The CMTA is a global leader in the acceleration of Read More
CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April Read More
Gene Therapy Advances for CMT4J, CMT4A and GAN
Steven Gray, PhD, an Associate Professor at the University of Read More
Progress in CMT2D Research
Timothy J. Hines, PhD, Postdoctoral Associate at The Jackson Laboratory Read More
A New Treatment for CMT1A
DTx Pharma is directly targeting the genetic cause for CMT1A Read More
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
The Charcot-Marie-Tooth Association added to its already deep bench of Read More
